Abramson J, Dobeš J, Lyu M, Sonnenberg GF.
2024.
The emerging family of RORγt+ antigen-presenting cells.. Nat Rev Immunol. 24(1):64-77.
Agbemelo-Tsomafo C, Adjei S, Kusi KA, Deitsch KW, Amoah D, Obeng-Kyeremeh R, Sumabe AM, Aniweh Y.
2023.
Prevalence of Leucocytozoon infection in domestic birds in Ghana.. PLoS One. 18(11):e0294066.
Ahmed A, Joseph AM, Zhou J, Horn V, Uddin J, Lyu M, Goc J, Sockolow RE, Wing JB, Vivier E et al..
2024.
CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation.. Nature. 630(8018):976-983.
Aldridge BB, Barros-Aguirre D, Barry CE, Bates RH, Berthel SJ, Boshoff HI, Chibale K, Chu X-J, Cooper CB, Dartois V et al..
2021.
The Tuberculosis Drug Accelerator at year 10: what have we learned? Nat Med. 27(8):1333-1337.
Allred DR, Barbet AF, J Barry D, Deitsch KW.
2009.
varDB: common ground for a shifting landscape.. Trends Parasitol. 25(6):249-52.
Anand VK, Kacker A, Orjuela AF, Huang C, Manarey C, Xiang JZ.
2006.
Inflammatory pathway gene expression in chronic rhinosinusitis.. Am J Rhinol. 20(4):471-6.
Anastassopoulou CG, Ketas TJ, Klasse PJohan, Moore JP.
2009.
Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41.. Proc Natl Acad Sci U S A. 106(13):5318-23.
Arias AA, Neehus A-L, Ogishi M, Meynier V, Krebs A, Lazarov T, Lee AM, Arango-Franco CA, Yang R, Orrego J et al..
2024.
Tuberculosis in otherwise healthy adults with inherited TNF deficiency.. Nature. 633(8029):417-425.
Aste-Amezaga M, Ma X, Sartori A, Trinchieri G.
1998.
Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10.. J Immunol. 160(12):5936-44.
Athapattu US, Amarasekara CA, Immel JR, Bloom S, Barany F, Nagel AC, Soper SA.
2021.
Solid-phase XRN1 reactions for RNA cleavage: application in single-molecule sequencing.. Nucleic Acids Res. 49(7):e41.